A detailed history of Ironwood Financial, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Ironwood Financial, LLC holds 3,535 shares of BIIB stock, worth $614,347. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,535
Previous 3,614 2.19%
Holding current value
$614,347
Previous $837,000 18.16%
% of portfolio
0.14%
Previous 0.19%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$189.07 - $236.8 $14,936 - $18,707
-79 Reduced 2.19%
3,535 $685,000
Q2 2023

Jul 20, 2023

SELL
$275.25 - $318.06 $55,050 - $63,612
-200 Reduced 5.24%
3,614 $1.03 Million
Q4 2021

Jan 28, 2022

BUY
$223.92 - $287.77 $4,478 - $5,755
20 Added 0.53%
3,814 $915,000
Q3 2021

Nov 02, 2021

BUY
$282.99 - $369.05 $92,820 - $121,048
328 Added 9.46%
3,794 $1.07 Million
Q1 2021

Apr 28, 2021

BUY
$242.95 - $284.63 $23,323 - $27,324
96 Added 2.85%
3,466 $970,000
Q4 2020

Jan 26, 2021

BUY
$236.26 - $355.63 $796,196 - $1.2 Million
3,370 New
3,370 $825,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Ironwood Financial, LLC Portfolio

Follow Ironwood Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironwood Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironwood Financial, LLC with notifications on news.